Top story Michael Burry's AI Bomb: Is a 'Safety' Slowdown Just a Power Play for OpenAI and Anthropic?
Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope